DrugPatentWatch Database Preview
Zydus Pharms Usa Company Profile
What is the competitive landscape for ZYDUS PHARMS USA, and when can generic versions of ZYDUS PHARMS USA drugs launch?
ZYDUS PHARMS USA has one hundred and ninety-six approved drugs.
There is one US patent protecting ZYDUS PHARMS USA drugs. There are nine tentative approvals on ZYDUS PHARMS USA drugs.
There are two patent family members on ZYDUS PHARMS USA drugs in two countries and two hundred and sixty-four supplementary protection certificates in thirteen countries.
Summary for Zydus Pharms Usa
| International Patents: | 2 |
| US Patents: | 1 |
| Tradenames: | 163 |
| Ingredients: | 162 |
| NDAs: | 196 |
Drugs and US Patents for Zydus Pharms Usa
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Zydus Pharms Usa Inc | CLOMIPRAMINE HYDROCHLORIDE | clomipramine hydrochloride | CAPSULE;ORAL | 208961-002 | Dec 27, 2017 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Zydus Pharms Usa Inc | LABETALOL HYDROCHLORIDE | labetalol hydrochloride | TABLET;ORAL | 207743-002 | Sep 19, 2017 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Zydus Pharms Usa Inc | PRAMIPEXOLE DIHYDROCHLORIDE | pramipexole dihydrochloride | TABLET, EXTENDED RELEASE;ORAL | 202891-005 | Dec 12, 2017 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Zydus Pharms Usa Inc | ZIPRASIDONE HYDROCHLORIDE | ziprasidone hydrochloride | CAPSULE;ORAL | 208988-001 | Aug 22, 2017 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Zydus Pharms Usa Inc | CLOBETASOL PROPIONATE | clobetasol propionate | SPRAY;TOPICAL | 206378-001 | Feb 16, 2017 | AT | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Paragraph IV (Patent) Challenges for ZYDUS PHARMS USA drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Delayed-release Tablets | 20 mg | ➤ Subscribe | 2015-06-03 |
International Patents for Zydus Pharms Usa Drugs
| Country | Document Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2011089623 | ➤ Sign Up |
| Japan | 2013516459 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for Zydus Pharms Usa Drugs
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| C/GB03/023 | United Kingdom | ➤ Sign Up | PRODUCT NAME: EZETIMIBE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF; REGISTERED: DE 54486.00.00 20021017; DE 54488.00.00 20021017; DE 54487.00.00 20021017; DE 54489.00.00 20021017; UK PL 19945/0001 20030404; UK PL 19945/0002 20030404 |
| C0041 | France | ➤ Sign Up | PRODUCT NAME: ATOMOXETINE OPTIONNELLEMENT SOUS FORME D'UN SEL TEL QUE LE CHLORHYDRATE; NAT. REGISTRATION NO/DATE: NL36369 20100628; FIRST REGISTRATION: GB - PL 00006/0374 20040527 |
| 0648494/01 | Switzerland | ➤ Sign Up | PRODUCT NAME: SIROLIMUS; REGISTRATION NO/DATE: IKS 55243 20000926 |
| C/GB01/047 | United Kingdom | ➤ Sign Up | PRODUCT NAME: NATEGLINIDE; REGISTERED: CH 55401 01 20000928; CH 55401 02 20000928; UK EU/1/01/174/001 20010403; UK EU/1/01/174/002 20010403; UK EU/1/01/174/003 20010403; UK EU/1/01/174/004 20010403; UK EU/1/01/174/005 20010403; UK EU/1/01/174/006 20010403; UK EU/1/01/174/007 20010403; UK EU/1/01/174/008 20010403; UK EU/1/01/174/009 20010403; UK EU/1/01/174/010 20010403; UK EU/1/01/174/011 20010403; UK EU/1/01/174/012 20010403; UK EU/1/01/174/013 20010403; UK EU/1/01/174/014 20010403; UK EU/1/01/174/015 20010403; UK EU/1/01/174/016 20010403; UK EU/1/01/174/017 20010403; UK EU/1/01/174/018 20010403; UK EU/1/01/174/019 20010403; UK EU/1/01/174/020 20010403; UK EU/1/01/174/021 20010403 |
| 00357 | Netherlands | ➤ Sign Up | PRODUCT NAME: SITAGLIPTINE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVA ARDBAAR ZOUT, IN HET BIJZONDER HET MONOFOSFAAT, EN METFORMINE DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, IN HET BIJZONDER HET HYDROCHLORIDE; REGISTRATION NO/DATE: EU/1/08/455/001-014 20080716 |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
